Crystalline form of (trans-4- [ ( { 5- [ (3, 4 -di fluorophenyl) amino] -1,3, 4-oxadiazol-2-yl}carbonyl) amino) phenyl } cyclohexyl) acetic acid

Details for Australian Patent Application No. 2007259031 (hide)

Owner AstraZeneca AB

Inventors Grundy, Walter; Dobson, Andrew Hornby

Agent Davies Collison Cave

Pub. Number AU-A-2007259031

PCT Pub. Number WO2007/144571

Priority 0611552.1 12.06.06 GB

Filing date 8 June 2007

Wipo publication date 21 December 2007

International Classifications

C07D 271/113 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

18 December 2008 PCT application entered the National Phase

  PCT publication WO2007/144571 Priority application(s): WO2007/144571

10 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007259032-A container and method of using the same

2007259030-Improvements relating to target tracking